Tae Hun Kim

Mr. Tae Hun Kim

Hanyang University Seoul Hospital, Seoul, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2023 in Biomaterials
Verified
Journal Article
Open access
SSSoraya Salas-Silva
Soraya Salas-Silva
YKYohan Kim
Yohan Kim
TKTae Hun Kim
Tae Hun Kim
MKMyounghoi Kim
Myounghoi Kim
DSDaekwan Seo
Daekwan Seo
DCDongho Choi
Dongho Choi
Several types of human stem cells from embryonic (ESCs) and induced pluripotent (iPSCs) to adult tissue-specific stem cells are commonly used to generate 3D liver organoids for modeling tissue physiology and disease. We have recently established a protocol for direct conversion of primary human hepatocytes (hPHs) from healthy donor livers into bipotent progenitor cells (hCdHs). Here we extended this culture system to generate hCdH-derived liver organoids for diverse biomedical applications. To obtain hCdHs, hPHs were cultured in reprogramming medium containing A83-01 and CHIR99021 for 7 days. Liver organoids were established from hCdHs (hCdHOs) and human liver cells (hLOs) using the same donor livers for direct comparison, as well as from hiPSCs. Organoid properties were analyzed by standard in vitro assays. Molecular changes were determined by RT-qPCR and RNA-seq. Clinical relevance was evaluated by transplantation into FRG mice, modeling of alcohol-related liver disease (ARLD), and in vitro drug-toxicity tests. hCdHs were clonally expanded as organoid cultures with low variability between starting hCdH lines. Similar to the hLOs, hCdHOs stably maintained stem cell phenotype based on accepted criteria. However, hCdHOs had an advantage over hLOs in terms of EpCAM expression, efficiency of organoid generation and capacity for directed hepatic differentiation as judged by molecular profiling, albumin secretion, glycogen accumulation, and CYP450 activities. Accordingly, FRG mice transplanted with hCdHOs survived longer than mice injected with hLOs. When exposed to ethanol, hCdHOs developed stronger ARLD phenotype than hLOs as evidenced by transcriptional profiling, lipid accumulation and mitochondrial dysfunction. In drug-induced injury assays in vitro, hCdHOs showed a similar or higher sensitivity response than hPHs. hCdHOs provide a novel patient-specific stem cell-based platform for regenerative medicine, toxicology testing and modeling liver diseases.

22 May 2024 in International Journal of Stem Cells
Verified
Journal Article
Open access
PDF file
HMHye-Ran Moon
Hye-Ran Moon
SMSeon Ju Mun
Seon Ju Mun
TKTae Hun Kim
Tae Hun Kim
HKHYEMIN KIM
HYEMIN KIM
DKDukjin Kang
Dukjin Kang
MSMyung Jin Son
Myung Jin Son
Hye-Ran Moon, Seon Ju Mun, Tae Hun Kim, Hyemin Kim, Dukjin Kang, Suran Kim, Ji Hyun Shin, Dongho Choi, Sun-Ju Ahn, Myung Jin Son. IJSC -0001;0:. https://doi.org/10.15283/ijsc24044

29 March 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
SLSuman Lee
Suman Lee
YHYukyung Hwang
Yukyung Hwang
TKTae Hun Kim
Tae Hun Kim
JJJaemin Jeong
Jaemin Jeong
DCDongho Choi
Dongho Choi
JHJungwook Hwang
Jungwook Hwang
Human hepatocellular carcinoma (HCC) has a high mortality rate because of the dearth of effective treatments. Multiple studies have shown that overexpression of UPF1, a key nonsense-mediated mRNA decay (NMD) factor, reduces HCC growth through various cell signaling pathways. However, the mechanism by which UPF1 expression retards HCC proliferation through the regulation of RNA stability remains unclear. By employing various UPF1 variants and transcriptome analysis, we revealed that overexpression of UPF1 variants, not UPF1-mediated NMD, reduces HCC tumorigenesis. Additionally, UPF1 variant overexpression reduced tumorigenesis in xenografted mice. Transcriptome analysis indicated that the level of dual specificity phosphatase 1 (DUSP1) was increased by UPF1 variants via posttranscriptional regulation. The UPF1 overexpression-mediated increase of DUSP1 activated tumor suppressor signaling, ultimately inhibiting cell growth. In this study, we highlighted the function of UPF1 as a tumor suppressor in HCC growth.

23 March 2022 in Biology
Verified
Journal Article
Open access
PDF file
JJJaemin Jeong
Jaemin Jeong
TKTae Hun Kim
Tae Hun Kim
MKMyounghoi Kim
Myounghoi Kim
YJYun Kyung Jung
Yun Kyung Jung
KKKyeong Sik Kim
Kyeong Sik Kim
DCDongho Choi
Dongho Choi
Hepatocytes and hepatic organoids (HOs) derived from human induced pluripotent stem cells (hiPSCs) are promising cell-based therapies for liver diseases. The removal of reprogramming transgenes can affect hiPSC differentiation potential into the three germ layers but not into hepatocytes and hepatic organoids in the late developmental stage. Herein, we generated hiPSCs from normal human fibroblasts using an excisable polycistronic lentiviral vector based on the Cre recombinase-mediated removal of the loxP-flanked reprogramming cassette. Comparing the properties of transgene-carrying and transgene-free hiPSCs with the same genetic background, the pluripotent states of all hiPSCs were quite similar, as indicated by the expression of pluripotent markers, embryonic body formation, and tri-lineage differentiation in vitro. However, after in vitro differentiation into hepatocytes, transgene-free hiPSCs were superior to the transgene-residual hiPSCs. Interestingly, the generation and hepatic differentiation of human hepatic organoids (hHOs) were significantly enhanced by transgene elimination from hiPSCs, as observed by the upregulated fetal liver (CK19, SOX9, and ITGA6) and functional hepatocyte (albumin, ASGR1, HNF4α, CYP1A2, CYP3A4, and AAT) markers upon culture in differentiation media. Thus, the elimination of reprogramming transgenes facilitates hiPSC differentiation into hepatocyte-like cells and hepatic organoids with properties of liver progenitor cells. Our findings thus provide significant insights into the characteristics of iPSC-derived hepatic organoids.

30 April 2022 in Annals of Hepato-Biliary-Pancreatic Surgery
Verified
Journal Article
Open access
PDF file
TKTae Hun Kim
Tae Hun Kim
JJJaemin Jeong
Jaemin Jeong
SSSehwan Shim
Sehwan Shim
HJHyosun Jang
Hyosun Jang
WJWon Il Jang
Won Il Jang
DCDongho Choi
Dongho Choi
Tae Hun KIM, Jaemin JEONG, Sehwan Shim, Hyosun Jang, Won Il Jang, Seung Bum Lee, Dongho Choi*. Ann Hepatobiliary Pancreat Surg 2022;26:S57. https://doi.org/10.14701/ahbps.2022S1.BR-OP-7

1 January 2024 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
MKMin Kim
Min Kim
TKTae Hun Kim
Tae Hun Kim
ESElsy Soraya Silva Salas
Elsy Soraya Silva Salas
SJSoyoung Jeon
Soyoung Jeon
JSJi Hyun Shin
Ji Hyun Shin
DCDongho Choi
Dongho Choi
Kim M, et al. Ann Surg Treat Res. 2024 Nov;107(5):252-263. https://doi.org/10.4174/astr.2024.107.5.252